Cost effectiveness of the direct measurement of 3-beta-hydroxybutyrate in the management of diabetic ketoacidosis in children.
Vanelli
Maurizio
M
Chiari
Giovanni
G
Capuano
Ciro
C
D020155:3-Hydroxybutyric Acid / Q000032:analysis / Q000191:economics*; D002648:Child; D003362:Cost-Benefit Analysis; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis* / Q000191:economics*; D016883:Diabetic Ketoacidosis / Q000175:diagnosis* / Q000191:economics*; D006801:Humans
D020155:3-Hydroxybutyric Acid